Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22328879 | 0.88 | PIM1 (0.30) | — | |
| SCHEMBL21704886 | 0.81 | GPR3 (0.31) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL22328865 | 0.76 | GPR84 (0.38) | ALDH1A1MAPTHPGD | |
| SCHEMBL13706277 | 0.76 | GPR3 (0.36) | PTPN1GPR3ALDH1A1MAPTHPGD | |
| SCHEMBL21454554 | 0.75 | GPR3 (0.47) | PTPN1GPR3ALDH1A1MAPTHPGD | |
| SCHEMBL12683580 | 0.75 | GPR3 (0.38) | PTPN1NQO1NQO2GPR3ALDH1A1 | |
| SCHEMBL25128993 | 0.75 | ESR1 (0.39) | PTPN1NQO2ALDH1A1MAPTHPGD | |
| SCHEMBL22328891 | 0.75 | MAPT (0.40) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL25007347 | 0.74 | F9 (0.34) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23463805 | 0.74 | F9 (0.34) | GPR3ALDH1A1MAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200255358-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255358-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNL2, MCM4, CCNT1 | PTPN1 4250/4885NQO1 1491/4885NQO2 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.